Gene · 388
Papers2,874
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,161 to 1,180 of 2,874
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inhibition of Protein Prenylation of GTPases Alters Endothelial Barrier Function. | Int J Mol Sci | 2019 | 31861297 | PubTator, text mining | PubMed |
| Perturbations in Lineage Specification of Granulosa and Theca Cells May Alter Corpus Luteum Formation and Function. | Front Endocrinol (Lausanne) | 2019 | 31849844 | PubTator, text mining | PubMed |
| Genetic deletion of Sphk2 confers protection against Pseudomonas aeruginosa mediated differential expression of genes related to virulent infection and inflammation in mouse lung. | BMC Genomics | 2019 | 31842752 | PubTator, text mining | PubMed |
| Molecular determinants of nephron vascular specialization in the kidney. | Nat Commun | 2019 | 31836710 | PubTator, text mining | PubMed |
| The Emerging Landscape of p53 Isoforms in Physiology, Cancer and Degenerative Diseases. | Int J Mol Sci | 2019 | 31835844 | PubTator, text mining | PubMed |
| Electromagnetic Properties of Carbon Gels. | Materials (Basel) | 2019 | 31835642 | PubTator, text mining | PubMed |
| Traumatic Brain Injuries: Pathophysiology and Potential Therapeutic Targets. | Front Cell Neurosci | 2019 | 31827423 | PubTator, text mining | PubMed |
Reduced expression of microRNA-139-5p in hepatocellular carcinoma results in a poor outcome: An exploration the roles of microRNA-139-5p in tumorigenesis, advancement and prognosis at the molecular biological level using an integrated meta-analysis and bioinformatic investigation. | Oncol Lett | 2019 | 31807180 | PubTator, text mining | PubMed |
| Expression And Biological Interaction Network Of RHOC For Hepatic Carcinoma With Metastasis In PBMC Samples. | Onco Targets Ther | 2019 | 31806997 | PubTator, text mining | PubMed |
| RASSF1A, puppeteer of cellular homeostasis, fights tumorigenesis, and metastasis-an updated review. | Cell Death Dis | 2019 | 31804463 | PubTator, text mining | PubMed |
| FAM53A Affects Breast Cancer Cell Proliferation, Migration, and Invasion in a p53-Dependent Manner. | Front Oncol | 2019 | 31799197 | PubTator, text mining | PubMed |
| Molecular Mechanisms and Anticancer Therapeutic Strategies in Vasculogenic Mimicry. | J Cancer | 2019 | 31772665 | PubTator, text mining | PubMed |
| Spatiotemporal Control of Intracellular Membrane Trafficking by Rho GTPases. | Cells | 2019 | 31766364 | PubTator, text mining | PubMed |
Role of the YAP-1 Transcriptional Target cIAP2 in the Differential Susceptibility to Chemotherapy of Non-Small-Cell Lung Cancer (NSCLC) Patients with Tumor RASSF1A Gene Methylation from the Phase 3 IFCT-0002 Trial. | Cancers (Basel) | 2019 | 31766357 | PubTator, text mining | PubMed |
| LncRNA SNHG8 is identified as a key regulator of acute myocardial infarction by RNA-seq analysis. | Lipids Health Dis | 2019 | 31739782 | PubTator, text mining | PubMed |
| From Genetics to Epigenetics, Roles of Epigenetics in Inflammatory Bowel Disease. | Front Genet | 2019 | 31737035 | PubTator, text mining | PubMed |
| Altered expression of microRNA-223 in the plasma of patients with first-episode schizophrenia and its possible relation to neuronal migration-related genes. | Transl Psychiatry | 2019 | 31712567 | PubTator, text mining | PubMed |
| Environmental Elasticity Regulates Cell-type Specific RHOA Signaling and Neuritogenesis of Human Neurons. | Stem Cell Reports | 2019 | 31708476 | PubTator, text mining | PubMed |
| System-level responses to cisplatin in pro-apoptotic stages of breast cancer MCF-7 cell line. | Comput Biol Chem | 2019 | 31706153 | PubTator, text mining | PubMed |
| The Role and Function of microRNA in the Pathogenesis of Multiple Myeloma. | Cancers (Basel) | 2019 | 31698726 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/388/papers?page=59